Advertisement

Topics

EchoNous Company Profile

08:06 EDT 23rd July 2018 | BioPortfolio

Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company and parent company of Signostics, is developing an expanding family of intelligent medical tools to help healthcare professionals solve common everyday problems in healthcare. Beginning with the soon-to-be-released EchoNous Vein vascular access tool (pending FDA approval) and the Uscan intelligent bladder scanner, EchoNous is applying a layer of artificial intelligence methods with the extreme miniaturized ultrasound technology to provide nurses, doctors and clinicians with high-quality, easy-to-use tools simplifying the task at hand. CEO and industry innovator Kevin Goodwin along with COO Niko Pagoulatos, Ph.D., a prolific engineering innovator, together direct the company based on decades of successful experience and new category creation in the ultrasound industry. For more information, visit www.echonous.com.


News Articles [4 Associated News Articles listed on BioPortfolio]

EchoNous Announces Biomedical Engineers and Managers Receive Hands-On Preview of New Multi-Function, Vascular and Bladder Nursing Platform at AAMI 2018

Pending FDA 510k clearance, new vein finding tool will enable first ever multi-function nursing platform alongside AI-driven bladder tool EchoNous, a developer of intel...

EchoNous Vein Receives FDA Approval, A New Innovation Designed for Nurses to Improve First-Time Peripheral IV Catheter Insertion

Product launch enables new multi-function, vascular access and bladder measurement platform designed to improve patient care, HCAHPS results, and save nursing time Echo...

EchoNous Names Point-of-Care Ultrasound Leader and Educational Pioneer Michael Blaivas, M.D., MBA, as Chief Medical Officer

An “original” POCUS user and educator in emergency medicine since 1993 EchoNous, a developer of intelligent medical tools, announces that Michael Blaivas, M.D., MBA...

Critical Care Nurses Attending NTI 2018 Will Have Hands-On Preview of EchoNous’ New Vein Finding Tool

Pending FDA 510k clearance, new vein finding tool is designed to improve first-time peripheral IV (PIV) placement and help improve HCAHPS patient satisfaction scores Ec...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

EchoNous

Headquartered in Seattle, Washington, EchoNous, a KKR portfolio company and parent company of Signostics, is developing an expanding family of intelligent medical tools to help he...

More Information about "EchoNous" on BioPortfolio

We have published hundreds of EchoNous news stories on BioPortfolio along with dozens of EchoNous Clinical Trials and PubMed Articles about EchoNous for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EchoNous Companies in our database. You can also find out about relevant EchoNous Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Blood
Blood is a specialized bodily fluid that delivers necessary substances to the body's cells (in animals) – such as nutrients and oxygen – and transports waste products away from those same cells.  In vertebrates, it is composed of blo...

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...


Corporate Database Quicklinks



Searches Linking to this Company Record